EIDX ALERT - Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ:EIDX) for Potential Securities Violations and Breach of Fiduciary Duty
Back to Newsroom
Mentioned in this Article

EIDX ALERT - Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ:EIDX) for Potential Securities Violations and Breach of Fiduciary Duty

Tuesday, December 29, 2020 11:15 AM
Share this article now
Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / December 29, 2020 / Labaton Sucharow, a nationally ranked shareholder rights firm, is investigating potential securities violations and breach of fiduciary duty claims against clinical-stage biotech company Eidos Therapeutics. (NASDAQ:EIDX).

If you currently own shares of Eidos and want to receive additional information and protect your investments free of charge, please contact David J. Schwartz using the toll free number (800) 321-0476 or via email at [email protected].

About the Firm

Labaton Sucharow LLP is one of the world's leading complex litigation firms representing clients in securities, antitrust, corporate governance and shareholder rights, and consumer cybersecurity and data privacy litigation. Labaton Sucharow has been recognized for its excellence by the courts and peers, and it is consistently ranked in leading industry publications. Offices are located in New York, NY, Wilmington, DE, and Washington, D.C. More information about Labaton Sucharow is available at http://www.labaton.com.

Contact: 

David J. Schwartz
(800) 321-0476
[email protected]

SOURCE: Labaton Sucharow LLP

Labaton Sucharow LLP
Back to Newsroom
Copyright 2021 © ACCESSWIRE. All rights reserved. Privacy Policy  |   Terms and Conditions